Today in the Market Restaurant you will find Collaborative Sourcing co-founders Graham and Matthew. They're eager to discuss the biggest challenges facing life science companies in 2025 as they grow and develop. The company helps pharmaceutical companies break free of traditional, siloed procurement behaviours and achieve more efficient supply chains, drive innovation, and improve patient access to medicines. Stop by between 10am and 3pm for a chat.
Babraham Research Campus’ Post
More Relevant Posts
-
“There are no villains, just misaligned incentives. To ensure patients get the medicines they need when they need them, resilient supply chains must be economically viable.” 💬 Vimala Raghavendran | US Pharmacopeia VP, Digital and Innovation Last week, Vimala joined fellow public health experts at Milken Institute’s Future of Health Summit to discuss the present and future of pharmaceutical supply chains. Moderated by Sarah Karlin-Smith, the panel featured Kirk Kaminsky (McKesson), Laura Bray (Angels for Change), and Shamiram Feinglass MD, MPH (Manatt, Phelps & Phillips, LLP). Click ⤵ to watch this engaging conversation and hear more insights from panelists, including: 💡 Low-margin generics are the “salt and pepper” of the healthcare industry, but manufacturers often can’t stay in business producing them. 💡 Investment in workforce training only helps bring more API manufacturing to the US if the economics of the drug product are viable. 💡 While individual hospitals and manufacturers know the status of their own supply chains and stockpiles, the system as a whole struggles to synchronize these dispersed knowledge bases. #MIHealthSummit #SupplyChain #PublicHealth
-
Ireland’s strategic location, strong infrastructure, and proven ability to maintain high production standards during global disruptions make it a vital player in the global biopharma supply chain and a critical hub for addressing health emergencies. As the sector evolves, Ireland’s pharmaceutical industry can further enhance its competitive advantage by capitalizing on its expertise in talent development, supply chain resilience, operational excellence, and regulatory leadership. Want to discover more? Click here to learn more: ➡️ https://lnkd.in/eahikNNp
-
-
Ready to take your biopharma company to the next level? Our whitepaper uncovers the seven key factors for a successful first drug launch in Europe, including pricing strategies, market positioning, and common pitfalls to avoid. Learn from 4,500 data points and expert insights to build a winning launch strategy. Discover our insights: skp.link/yhq7 #BetterMarketAccess #SimonKucher #Biopharma #FirstDrugLaunch #CommercialExcellence
-
-
Senior Manager Knowledge and Research bei Simon-Kucher & Partners - Teamlead Business Research
Ready to take your biopharma company to the next level? Our whitepaper uncovers the seven key factors for a successful first drug launch in Europe, including pricing strategies, market positioning, and common pitfalls to avoid. Learn from 4,500 data points and expert insights to build a winning launch strategy. Discover our insights: skp.link/yhq7 #BetterMarketAccess #SimonKucher #Biopharma #FirstDrugLaunch #CommercialExcellence
-
-
Ready to take your biopharma company to the next level? Our whitepaper uncovers the seven key factors for a successful first drug launch in Europe, including pricing strategies, market positioning, and common pitfalls to avoid. Learn from 4,500 data points and expert insights to build a winning launch strategy. Discover our insights: skp.link/yhq7 #BetterMarketAccess #SimonKucher #Biopharma #FirstDrugLaunch #CommercialExcellence
-
-
Ready to take your biopharma company to the next level? Our whitepaper uncovers the seven key factors for a successful first drug launch in Europe, including pricing strategies, market positioning, and common pitfalls to avoid. Learn from 4,500 data points and expert insights to build a winning launch strategy. Discover our insights: skp.link/yhq7 #BetterMarketAccess #SimonKucher #Biopharma #FirstDrugLaunch #CommercialExcellence
-
-
Ready to take your biopharma company to the next level? Our whitepaper uncovers the seven key factors for a successful first drug launch in Europe, including pricing strategies, market positioning, and common pitfalls to avoid. Learn from 4,500 data points and expert insights to build a winning launch strategy. Discover our insights: skp.link/yhq7 #BetterMarketAccess #SimonKucher #Biopharma #FirstDrugLaunch #CommercialExcellence
-
-
Ready to take your biopharma company to the next level? Our whitepaper uncovers the seven key factors for a successful first drug launch in Europe, including pricing strategies, market positioning, and common pitfalls to avoid. Learn from 4,500 data points and expert insights to build a winning launch strategy. Discover our insights: skp.link/yhq7 #BetterMarketAccess #SimonKucher #Biopharma #FirstDrugLaunch #CommercialExcellence
-
-
The frequency of payer/pharma meetings has increased, but the duration has decreased in the past year. https://ow.ly/wqe150SmI7p MMIT's Jonathan Cecire and Norstella's Dinesh Kannan Kabaleeswaran look at what the latest trends tell us about how pharma companies can advocate for better formulary positioning for their products. #PharmaCompanies #PharmaInsights #Formularies
-
We’re here and excited to meet 👋